Table 2C.

Multivariable analysis for cancer-specific mortality.

Variable	Hazard ratio (HR)	95% CI Low	95% CI High	p
Age (continuous)	1.02	1.00	1.03	0.013
Sex (female vs. male)	0.97	0.74	1.29	0.85
Race (other vs. AA)	1.070	0.73	1.57	0.73
BMI (continuous)	1.01	0.99	1.03	0.32
CAD (no vs. yes)	1.14	0.85	1.53	0.38
DM (no vs. yes)	1.35	0.95	1.94	0.10
Tumor stage (reference = Stage 1)				p<0.001
Stage 2 vs. Stage 1	3.04	1.52	6.09	0.002
Stage 3 vs. Stage 1	3.94	2.31	6.72	<0.001
Stage 4 vs. Stage 1	9.21	5.28	16.05	<0.001
Metastasis (no vs. yes)	4.29	2.97	6.21	<0.001
Nuclear Grade (3/4 vs. 1/2)	2.23	1.52	3.28	<0.001
Surgery (RN vs. PN)	1.61	1.14	2.33	0.007
Clear cell histology (yes vs. no)	1.45	1.02	2.04	0.038
Last eGFR < 45 ml/min/1.73m² (no vs. yes)	1.25	0.96	1.63	0.097
NLR ≥ 2.27 (no vs. yes)	1.08	0.80	1.46	0.60
PLR ≥ 165 (no vs. yes)	1.26	0.90	1.75	0.18
AST/ALT ≥ 2.72 (no vs. yes)	1.97	1.48	2.63	<0.001